David Guyer is the founder of Eyebiotech. Eyebiotech has raised $130M in total funding. Latest round: Series A. Based in San Francisco, California.
David Guyer, M.D., is the CEO and co-founder of EyeBio (Eyebiotech), an ophthalmology biotechnology company founded in August 2021 to develop therapies for sight-threatening eye diseases. He previously served as a Partner and Venture Partner at SV Health Investors, the firm that seeded and created EyeBio, before re-joining SV as a Venture Partner in 2021 while taking on the CEO role at EyeBio.
Full founder directory · Investor directory · Company funding database · Fundraising library